Article info

Download PDFPDF
Carvedilol: the β-blocker of choice for portal hypertension?
  1. Correspondence to Professor Jaime Bosch, Liver Unit, Hospital Clínic-IDIBAPS, University of Barcelona and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hepatic Hemodynamic Laboratory, C. Villarroel 170, Barcelona 08036, Spain; jbosch{at}clinic.ub.es
View Full Text

Citation

Bosch J
Carvedilol: the β-blocker of choice for portal hypertension?

Publication history

  • First published January 26, 2013.
Online issue publication 
October 08, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.